Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease
出版年份 2023 全文链接
标题
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease
作者
关键词
-
出版物
CURRENT OPINION IN LIPIDOLOGY
Volume 34, Issue 3, Pages 105-113
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-03-16
DOI
10.1097/mol.0000000000000875
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
- (2022) Brian A. Bergmark et al. CIRCULATION
- Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver Disease
- (2022) Hangkai Huang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
- (2022) Calvin Yeang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
- (2022) Jan Borén et al. Nature Reviews Cardiology
- Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
- (2022) Paul M Ridker et al. CIRCULATION
- Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
- (2022) Liyao Fu et al. DIABETES CARE
- Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates
- (2022) Reza Mohebi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
- (2022) Ian H. de Boer et al. DIABETES CARE
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
- (2022) Florian Kronenberg et al. EUROPEAN HEART JOURNAL
- New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease
- (2022) Paul Nestel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease
- (2022) Martine Paquette et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)
- (2022) Parag Anilkumar Chevli et al. Journal of Clinical Lipidology
- Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 and ANGPTL3 (Angiopoietin-Like Protein 3)
- (2022) Henry N. Ginsberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
- (2022) Hidekatsu Yanai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes
- (2022) Francisco X. Barrera Echegoyen et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk
- (2021) Steven E. Nissen et al. JAMA Cardiology
- Cardiovascular disease in diabetes, beyond glucose
- (2021) Robert H. Eckel et al. Cell Metabolism
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021
- (2021) Tahreem Iqbal et al. Current Cardiology Reports
- Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Gissette Reyes-Soffer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial
- (2021) Rachel A. Warren et al. DIABETES CARE
- A Modern Approach to Dyslipidemia
- (2021) Amanda J Berberich et al. ENDOCRINE REVIEWS
- Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study
- (2021) Benjamin Nilsson Wadström et al. EUROPEAN HEART JOURNAL
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
- (2020) Børge G. Nordestgaard et al. ATHEROSCLEROSIS
- A PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD Lipid
- (2020) Mario Luca Morieri et al. DIABETES
- Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
- (2020) Alan Chait et al. DIABETES
- Contribution of remnant cholesterol to cardiovascular risk
- (2020) Anne Langsted et al. JOURNAL OF INTERNAL MEDICINE
- Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease
- (2020) Roy O. Mathew et al. CARDIOVASCULAR DRUGS AND THERAPY
- When to lower triglycerides?
- (2020) Om P. Ganda CURRENT OPINION IN LIPIDOLOGY
- Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
- (2020) Edward K Duran et al. CLINICAL CHEMISTRY
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
- (2020) John R. Burnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
- (2020) Mie Balling et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
- (2020) Olga Castañer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mendelian Randomization Study of ACLY and Cardiovascular Disease
- (2019) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
- (2019) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination
- (2019) Yamashita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid
- (2018) Samuel C.R. Sherratt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
- (2018) Om P. Ganda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased Residual Cardiovascular Risk in Patients with Diabetes and High vs. Normal Triglycerides Despite Statin-Controlled LDL Cholesterol
- (2018) Gregory A. Nichols et al. DIABETES OBESITY & METABOLISM
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Lipid management in patients with chronic kidney disease
- (2018) Charles J. Ferro et al. Nature Reviews Nephrology
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started